{
  "id": "Ex012",
  "type": "Example",
  "informationId": {
    "id": "CritAssess286",
    "type": "CriterionAssessment",
    "explanation": "The RASopathy group considers MEK and ERK activation assays as well validated.",
    "criterion": {
      "id": "PS3",
      "type": "Criterion",
      "description": "Well-established in vitro or in vivo functional studies supportive of a damaging effect on the gene or gene product",
      "shortDescription": "Well-established functional studies showing damaging effect",
      "defaultStrength": {
        "id": "CG-evidence-strength:ps"
      }
    },
    "variant": {
      "id": "CanAll020",
      "type": "CanonicalAllele",
      "preferredCtxAllele": "CtxAll023",
      "identifier": "http://reg.genome.network/allele/CA220161"
    },
    "outcome": {
      "id": "CG-criterion-outcome:met",
      "type": "Coding",
      "code": "met",
      "system": "http://clinicalgenome.org/datamodel/criterion-assertion-outcome/",
      "display": "Met"
    },
    "evidence": [
      {
        "id": "EvLn017",
        "type": "EvidenceLine",
        "explanation": "EvLn017",
        "information": [
          {
            "id": "Func026",
            "type": "FunctionalData",
            "result": "abnormal/deceased MEK activtation.",
            "dataType": {
              "id": "CC020",
              "type": "CodeableConcept",
              "coding": [
                {
                  "id": "CG-func-data-type:activation",
                  "type": "Coding",
                  "code": "activation",
                  "system": "http://clinicalgenome.org/datamodel/functional-data-type/",
                  "display": "Activation Assay"
                }
              ]
            },
            "contextualAllele": {
              "id": "CtxAll024",
              "type": "ContextualAllele",
              "relatedCanonicalAllele": {
                "id": "CanAll021",
                "type": "CanonicalAllele",
                "preferredCtxAllele": "CtxAll024",
                "identifier": "http://reg.genome.network/allele/CA093846"
              },
              "alleleName": "NP_004324.2:p.Gly596Val"
            },
            "gene": {
              "id": "hgnc:MEK",
              "type": "Gene",
              "symbol": "MEK"
            }
          }
        ]
      },
      {
        "id": "EvLn018",
        "type": "EvidenceLine",
        "explanation": "EvLn018",
        "information": [
          {
            "id": "Func027",
            "type": "FunctionalData",
            "result": "abnormal/deceased ERK activtation.",
            "dataType": {
              "id": "CC021",
              "type": "CodeableConcept",
              "coding": [
                {
                  "id": "CG-func-data-type:activation",
                  "type": "Coding",
                  "code": "activation",
                  "system": "http://clinicalgenome.org/datamodel/functional-data-type/",
                  "display": "Activation Assay"
                }
              ]
            },
            "contextualAllele": {
              "id": "CtxAll024",
              "type": "ContextualAllele",
              "relatedCanonicalAllele": {
                "id": "CanAll021",
                "type": "CanonicalAllele",
                "preferredCtxAllele": "CtxAll024",
                "identifier": "http://reg.genome.network/allele/CA093846"
              },
              "alleleName": "NP_004324.2:p.Gly596Val"
            },
            "gene": {
              "id": "hgnc:ERK",
              "type": "Gene",
              "symbol": "ERK"
            }
          }
        ]
      }
    ],
    "contribution": [
      {
        "type": "Contribution",
        "agent": {
          "id": "Agent001",
          "type": "Agent",
          "name": "Harry Stevenson"
        },
        "onDate": "6/4/16 7:12 AM",
        "role": {
          "id": "CC312",
          "type": "CodeableConcept",
          "coding": [
            {
              "id": "CG-contributory-role:assessor",
              "type": "Coding",
              "code": "assessor",
              "system": "http://clinicalgenome.org/datamodel/contributory-role/",
              "display": "assessor"
            }
          ]
        }
      },
      {
        "type": "Contribution",
        "agent": {
          "id": "Agent002",
          "type": "Agent",
          "name": "Noonan/Rasopathy WG (ClinGen)"
        },
        "onDate": "6/4/16 7:12 AM",
        "role": {
          "id": "CC313",
          "type": "CodeableConcept",
          "coding": [
            {
              "id": "CG-contributory-role:assessor",
              "type": "Coding",
              "code": "assessor",
              "system": "http://clinicalgenome.org/datamodel/contributory-role/",
              "display": "assessor"
            }
          ]
        }
      }
    ]
  },
  "index": 3,
  "author": "Steven Harrison",
  "description": "Assessed variant: NM_004333.4(BRAF):c.1787G>T (p.Gly596Val)  \nThe RASopathy group decided for BRAF both MEK activation and ERK activation assays (in which the variant results in abnormal pattern of pERK/ERK or pMEK/MEK) is a validated assay.\nPMID:16439621 shows that Gly596Val results in abnormal/decreased MEK and ERK activiation so PS3 is applicable for this variant "
}
